Gossamer Bio和Chiesi Farmaceutici今日宣布，双方已达成全球合作与许可协议，共同开发和商业化seralutinib，用于治疗肺动脉高压（PAH）以及间质性肺病相关 ...

Gossamer Bio, Inc. (Nasdaq: GOSS), a late-stage, clinical biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial ...

The Gossamer-1 project is concerned with the development and establishment of a space-qualified technology for the deployment of ultra-light, large foil structures in space. The core technologies are ...

SAN DIEGO, May 15, 2025--(BUSINESS WIRE)--Gossamer Bio, Inc. (Nasdaq: GOSS), a late-stage, clinical biopharmaceutical company focused on the development and commercialization of seralutinib for ...

When it comes to ultralight backpacking, every gram counts. That’s why I was eager to test the Gossamer Gear The One – a single-skin trekking pole tent that promises big space with minimal weight.

Gossamer Bio (GOSS) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates ...

Gossamer Bio's seralutinib shows promise for PAH and PH-ILD, with a clean long-term safety profile differentiating it from competitors like Winrevair. AVTE's AV-101 failed due to dose limitations ...

Gossamer Bio's lead asset, seralutinib, shows promise in Phase 2 for PAH, but Phase 3 efficacy and competition from established drugs remain concerns. The company is well capitalized with $295 ...

That's where Gossamer's new range of ultra-light packs aims to help - appropriately named as the Type 2 collection. The four new backcountry packs combine a minimalist design with multiple ...

GOSSAMER BIO ($GOSS) is expected to release its quarterly earnings data on Friday, March 21st after market close, per Finnhub. Analysts are expecting revenue of ...

The Gossamer Gear Whisper is one of the most impossible-looking tents I’ve ever seen. It’s a veritable palace for one person that packs up to the size of an oversized nalgene. There is also something ...